2m 2m 2m 2m 2m 2m 2m
ROCKET PHARMACTC (RCKT)
NASDAQ
$3.08-$0.03 (-0.96%)
Price as of Aug 03, 2026 6:48 AM EDT- $339.6MMarket Cap
- 4.01%1-Year Change
- BiotechnologyIndustry
ROCKET PHARMACTC (RCKT)
$3.08-$0.03 (-0.96%)
RCKT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.11 | ||
Change | -$0.10 (-3.12%) | ||
Open | $3.19 | ||
High | $3.21 | ||
Low | $3.05 | ||
Previous Close | $3.21 | ||
Volume | 1,281,506 | ||
30-Day Average Volume | 1,837,358 | ||
1-Week Change | -2.51% | ||
1-Month Change | -9.06% | ||
1-Year Change | 4.01% | ||
3-Year Change | -82.77% | ||
5-Year Change | -91.32% | ||
Fundamentals | |||
Shares Outstanding | 109.2M | ||
Total Assets | $285.4M | ||
Market Cap | $339.6M | ||
Enterprise Value | $290.8M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$47.6M | ||
Free Cash Flow | -$45.5M | ||
EBIT | -$47.1M | ||
EBITDA | -$45.5M | ||
Net Working Capital | $125.4M | ||
EPS | -$0.42 | ||
Enterprise Value/EBITDA | -6 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -7 | ||
PEG | 1 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue